The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers

Hamada A Mokhlis1, Recep Bayraktar2, Nashwa N Kabil2

  • 1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, The University of Al-Azhar, Cairo, Egypt.

Insights

MicroRNA-873 (miR-873) suppresses tumor growth by targeting KRAS in pancreatic and breast cancers. Restoring miR-873 inhibits cancer progression and may offer a novel gene therapy approach.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • KRAS mutations are common in pancreatic ductal adenocarcinoma (PDAC) and triple-negative breast cancer (TNBC).
  • MicroRNAs (miRNAs) play crucial roles in cancer development and therapy.
  • miR-873 was identified as a potential regulator of KRAS.

Purpose of the Study:

  • To investigate the role of miR-873 in PDAC and TNBC.
  • To determine if miR-873 targets KRAS and affects cancer progression.
  • To evaluate miR-873 as a potential therapeutic agent.

Main Methods:

  • In silico prediction algorithms to identify miR-873 as a KRAS regulator.
  • Analysis of miR-873 expression in cancer cell lines and patient samples.
  • In vitro experiments demonstrating miR-873 binding to KRAS mRNA and its effects on cancer cell behavior.
  • In vivo studies using nanoparticle delivery of miR-873 in mouse models.

Main Results:

  • Reduced miR-873 expression correlated with shorter survival in PDAC and TNBC patients.
  • miR-873 directly suppressed KRAS expression by binding to its 3' UTR.
  • Restoring miR-873 induced apoptosis, inhibited proliferation and invasion, and suppressed ERK and PI3K/AKT signaling.
  • KRAS overexpression rescued the anti-cancer effects of miR-873.
  • In vivo delivery of miR-873 nanoparticles inhibited tumor growth in PDAC and TNBC models.

Conclusions:

  • miR-873 functions as a tumor suppressor by targeting KRAS in PDAC and TNBC.
  • miR-873-based gene therapy holds promise for treating PDAC and TNBC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
9.8K
Role of Septins01:02

Role of Septins

Septins are the recently discovered fourth major protein component of the cytoskeleton, along with microfilaments, microtubules, and intermediate filaments. These proteins can associate with other cytoskeletal filaments and carry out varied roles or can be free-floating in the cytoplasm.
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
2.2K